Advanced Search
ZHU Hui, DENG Kangli. Current Status and Future Directions of Treatment of Post-prostatectomy Urinary Incontinence in Prostate Cancer[J]. Cancer Research on Prevention and Treatment, 2020, 47(10): 727-733. DOI: 10.3971/j.issn.1000-8578.2020.20.0838
Citation: ZHU Hui, DENG Kangli. Current Status and Future Directions of Treatment of Post-prostatectomy Urinary Incontinence in Prostate Cancer[J]. Cancer Research on Prevention and Treatment, 2020, 47(10): 727-733. DOI: 10.3971/j.issn.1000-8578.2020.20.0838

Current Status and Future Directions of Treatment of Post-prostatectomy Urinary Incontinence in Prostate Cancer

More Information
  • Corresponding author:

    DENG Kangli, E-mail: dengkangli10@163.com

  • Received Date: July 19, 2020
  • Revised Date: August 16, 2020
  • Available Online: January 12, 2024
  • Urinary incontinence is the most common adverse effects after radical prostatectomy, and it significantly impacts patients' quality of life after surgery. With the discovery of the fine anatomical structure of the prostate and the popularization of the concept of neurovascular bundle-sparing during surgery, the incidence of urinary incontinence after radical prostatectomy has been significantly reduced. Depending on the degree of urinary incontinence, the current treatment strategies include conservative treatment, behavioral therapy, pharmacotherapy, urethral bulking agents injection, male sling and artificial urethral sphincter. This article reviews the current status of treatment of urinary incontinence after radical prostatectomy, summarizes the scope of application, advantages and disadvantages of different treatment options and prospects for new treatment options in the future.

  • [1]
    Bekelman JE, Rumble RB, Freedland SJ. Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an AUA/ASTRO/SUO Guideline Summary[J]. J Oncol Pract, 2018, 14(10): 618-624. doi: 10.1200/JOP.18.00434
    [2]
    Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent[J]. Eur Urol, 2017, 71(4): 618-629. doi: 10.1016/j.eururo.2016.08.003
    [3]
    Sanda MG, Cadeddu JA, Kirkby E, et al. Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. PartⅡ: Recommended Approaches and Details of Specific Care Options[J]. J Urol, 2018, 199(4): 990-997. http://www.ncbi.nlm.nih.gov/pubmed/29331546
    [4]
    Sandhu JS, Breyer B, Comiter C, et al. Incontinence after Prostate Treatment: AUA/SUFU Guideline[J]. J Urol, 2019, 202(2): 369-378. http://www.researchgate.net/publication/332898385_Incontinence_after_Prostate_Treatment_AUASUFU_Guideline
    [5]
    Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors[J]. N Engl J Med, 2008, 358(12): 1250-1261. doi: 10.1056/NEJMoa074311
    [6]
    Kretschmer A, Hübner W, Sandhu JS, et al. Evaluation and Management of Postprostatectomy Incontinence: A Systematic Review of Current Literature[J]. Eur Urol Focus, 2016, 2(3): 245-259. doi: 10.1016/j.euf.2016.01.002
    [7]
    Moinzadeh A, Shunaigat AN, Libertino JA. Urinary incontinence after radical retropubic prostatectomy: the outcome of a surgical technique[J]. BJU Int, 2003, 92(4): 355-359.
    [8]
    Kretschmer A, Nitti V. Surgical Treatment of Male Postprostatectomy Incontinence: Current Concepts[J]. Eur Urol Focus, 2017, 3(4-5): 364-376. doi: 10.1016/j.euf.2017.11.007
    [9]
    Anderson CA, Omar MI, Campbell SE, et al. Conservative management for postprostatectomy urinary incontinence[J]. Cochrane Database Syst Rev, 2015, 1(1): CD001843. doi: 10.1002/14651858.cd001843.pub4
    [10]
    Comiter CV, Dobberfuhl AD. The artificial urinary sphincter and male sling for postprostatectomy incontinence: Which patient should get which procedure?[J]. Investig Clin Urol, 2016, 57(1): 3-13. doi: 10.4111/icu.2016.57.1.3
    [11]
    Geraerts I, Van Poppel H, Devoogdt N, et al. Influence of preoperative and postoperative pelvic floor muscle training (PFMT) compared with postoperative PFMT on urinary incontinence after radical prostatectomy: a randomized controlled trial[J]. Eur Urol, 2013, 64(5): 766-772. doi: 10.1016/j.eururo.2013.01.013
    [12]
    Bales GT, Gerber GS, Minor TX, et al. Effect of preoperative biofeedback/pelvic floor training on continence in men undergoing radical prostatectomy[J]. Urology, 2000, 56: 627-30. doi: 10.1016/S0090-4295(00)00687-7
    [13]
    Wang W, Huang QM, Liu FP, et al. Effectiveness of preoperative pelvic floor muscle training for urinary incontinence after radical prostatectomy: a meta-analysis[J]. BMC Urol, 2014, 14: 99. doi: 10.1186/1471-2490-14-99
    [14]
    Weber-Rajek M, Radzimińska A, Strączyńska A, et al. A randomized-controlled trial pilot study examining the effect of extracorporeal magnetic innervation in the treatment of stress urinary incontinence in women[J]. Clin Interv Aging, 2018, 13: 2473-2480. doi: 10.2147/CIA.S176588
    [15]
    Maserejian NN, Wager CG, Giovannucci EL, et al. Intake of caffeinated, carbonated, or citrus beverage types and development of lower urinary tract symptoms in men and women[J]. Am J Epidemiol, 2013, 177(12): 1399-1410. doi: 10.1093/aje/kws411
    [16]
    Wang R, McGuire EJ, He C, et al. Long-term outcomes after primary failures of artificial urinary sphincter implantation[J]. Urology, 2012, 79(4): 922-928. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=4a983b83d035763ced624a1353c45082
    [17]
    Diokno AC, Taub M. Ephedrine in treatment of urinary incontinence[J]. Urology, 1975, 5(5): 624-625. doi: 10.1016/0090-4295(75)90113-2
    [18]
    Awad SA, Downie JW, Kiruluta HG. Alpha-adrenergic agents in urinary disorders of the proximal urethra. Part I. Sphincteric incontinence[J]. Br J Urol, 1978, 50(5): 332-335. doi: 10.1111/j.1464-410X.1978.tb03642.x
    [19]
    Noguchi M, Eguchi Y, Ichiki J, et al. Therapeutic efficacy of clenbuterol for urinary incontinence after radical prostatectomy[J]. Int J Urol, 1997, 4(5): 480-483. doi: 10.1111/j.1442-2042.1997.tb00289.x
    [20]
    Zozikov B, Kunchev SI, Varlev C. Application of clenbuterol in the treatment of urinary incontinence[J]. Int Urol Nephrol, 2001, 33(3): 413-416. doi: 10.1023/A:1019565229886
    [21]
    Schlenker B, Gratzke C, Reich O, et al. Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy[J]. Eur Urol, 2006, 49(6): 1075-1078. doi: 10.1016/j.eururo.2006.01.038
    [22]
    Keefe J, Wauk L, Chu S, et al. Clinical use of injectable bovine collagen: a decade of experience[J]. Clin Mater, 1992, 9(3-4): 155-162. doi: 10.1016/0267-6605(92)90095-B
    [23]
    Leruth J, Waltregny D, de Leval J. The inside-out transobturator male sling for the surgical treatment of stress urinary incontinence after radical prostatectomy: midterm results of a single-center prospective study[J]. Eur Urol, 2012, 61(3): 608-615. http://www.sciencedirect.com/science/article/pii/S030228381101222X
    [24]
    Romano SV, Metrebian SE, Vaz F, et al.[Long-term results of a phase Ⅲ multicentre trial of the adjustable male sling for treating urinary incontinence after prostatectomy: minimum 3 years][J]. Actas Urol Esp, 2009, 33(3): 309-314. doi: 10.1016/S0210-4806(09)74146-4
    [25]
    Hübner WA, Gallistl H, Rutkowski M, et al. Adjustable bulbourethral male sling: experience after 101 cases of moderate-to-severe male stress urinary incontinence[J]. BJU Int, 2011, 107(5): 777-782. doi: 10.1111/j.1464-410X.2010.09619.x
    [26]
    Kretschmer A, Hüsch T, Thomsen F, et al. Targeting Moderate and Severe Male Stress Urinary Incontinence with Adjustable Male Slings and the Perineal Artificial Urinary Sphincter: Focus on Perioperative Complications and Device Explantations[J]. Int Neurourol J, 2017, 21(2): 109-115. doi: 10.5213/inj.1632626.313
    [27]
    Loertzer H, Huesch T, Kirschner-Hermanns R, et al. Retropubic vs. transobturator Argus adjustable male sling: Results from a multicenter study[J]. Neurourol Urodyn, 2020, 39(3): 987-993. doi: 10.1002/nau.24316
    [28]
    Angulo JC, Schönburg S, Giammò A, et al. Systematic review and meta-analysis comparing Adjustable Transobturator Male System (ATOMS) and Adjustable Continence Therapy (ProACT) for male stress incontinence[J]. PLoS One, 2019, 14(12): e0225762. doi: 10.1371/journal.pone.0225762
    [29]
    Ficarra V, Novara G, Rosen RC, et al. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy[J]. Eur Urol, 2012, 62(3): 405-417. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=99660f610d05464c513f88b64df729e9
    [30]
    Leizour B, Chevrot A, Wagner L, et al. Adjustable retropubic suburethral sling Remeex((R)) in the treatment of male stress urinary incontinence: One-year results[J]. Prog Urol, 2017, 27(4): 238-243. http://smartsearch.nstl.gov.cn/paper_detail.html?id=dd04009f437a0955c1ffde6ccdce6e1a
    [31]
    Lukacz ES, Santiago-Lastra Y, Albo ME, et al. Urinary Incontinence in Women: A Review[J]. JAMA, 2017, 318(16): 1592-1604. doi: 10.1001/jama.2017.12137
    [32]
    Collado A, Domínguez-Escrig J, Ortiz Rodríguez IM, et al. Functional follow-up after Advance((R)) and Advance XP((R)) male sling surgery: assessment of predictive factors[J]. World J Urol, 2019, 37(1): 195-200. doi: 10.1007/s00345-018-2357-9
    [33]
    Athanasopoulos A, Konstantinopoulos A, McGuire E. Efficacy of the InVance((TM)) male sling in treating stress urinary incontinence: a three-year experience from a single centre[J]. Urol Int, 2010, 85(4): 436-442. doi: 10.1159/000314918
    [34]
    Comiter CV, Nitti V, Elliot C, et al. A new quadratic sling for male stress incontinence: retrograde leak point pressure as a measure of urethral resistance[J]. J Urol, 2012, 187(2): 563-568. doi: 10.1016/j.juro.2011.09.152
    [35]
    Yiou R, Loche CM, Lingombet O, et al. Evaluation of urinary symptoms in patients with post-prostatectomy urinary incontinence treated with the male sling TOMS[J]. Neurourol Urodyn, 2015, 34(1): 12-17. doi: 10.1002/nau.22503
    [36]
    Linder BJ, Rivera ME, Ziegelmann MJ, et al. Long-term Outcomes Following Artificial Urinary Sphincter Placement: An Analysis of 1082 Cases at Mayo Clinic[J]. Urology, 2015, 86(3): 602-607. http://www.ncbi.nlm.nih.gov/pubmed/26135815
    [37]
    Kim SP, Sarmast Z, Daignault S, et al. Long-term durability and functional outcomes among patients with artificial urinary sphincters: a 10-year retrospective review from the University of Michigan[J]. J Urol, 2008, 179(5): 1912-1916. doi: 10.1016/j.juro.2008.01.048
    [38]
    O'Connor RC, Lyon MB, Guralnick ML, et al. Long-term follow-up of single versus double cuff artificial urinary sphincter insertion for the treatment of severe postprostatectomy stress urinary incontinence[J]. Urology, 2008, 71(1): 90-93. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=3c386203265ed88c04f63953aba53311
    [39]
    Gallo F, Ninotta G, Schenone M, et al. Advances in stem cell therapy for male stress urinary incontinence[J]. Expert Opin Biol Ther, 2019, 19(4): 293-300. doi: 10.1080/14712598.2019.1578343
    [40]
    Janssen K, Lin DL, Hanzlicek B, et al. Multiple doses of stem cells maintain urethral function in a model of neuromuscular injury resulting in stress urinary incontinence[J]. Am J Physiol Renal Physiol, 2019, 317(4): F1047-F1057. doi: 10.1152/ajprenal.00173.2019
    [41]
    Deng KL, Lin DL, Hanzlicek B, et al. Mesenchymal stem cells and their secretome partially restore nerve and urethral function in a dual muscle and nerve injury stress urinary incontinence model[J]. Am J Physiol Renal Physiol, 2015, 308(2): F92-F100. doi: 10.1152/ajprenal.00510.2014
    [42]
    Gotoh M, Yamamoto T, Kato M, et al. Regenerative treatment of male stress urinary incontinence by periurethral injection of autologous adipose-derived regenerative cells: 1-year outcomes in 11 patients[J]. Int J Urol, 2014, 21(3): 294-300. doi: 10.1111/iju.12266
  • Related Articles

    [1]ZHANG Shouyu, CHEN Bojiang, LI Weimin. Applications and Challenges of Artificial Intelligence in Early Diagnosis and Precise Treatment of Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2024, 51(12): 1000-1006. DOI: 10.3971/j.issn.1000-8578.2024.24.0755
    [2]NI Xinmiao, YANG Rui, CHEN Zhiyuan, LIU Xiuheng. Application and Development of Artificial Intelligence in A Pathological Study of Urinary System Tumors[J]. Cancer Research on Prevention and Treatment, 2023, 50(2): 113-118. DOI: 10.3971/j.issn.1000-8578.2023.22.0752
    [3]WEI Ning, LIN Ruijiang, MA Minjie, CHEN Chang, HAN Biao. Relation Between Imaging Microfeatures of Artificial Intelligence-assisted Diagnosis System and Prognosis of Lung Adenocarcinomas Presented as Ground-glass Nodules[J]. Cancer Research on Prevention and Treatment, 2021, 48(9): 877-882. DOI: 10.3971/j.issn.1000-8578.2021.21.0255
    [4]YANG Wenjing, LYV Zhangyan, FENG Xiaoshuang, WANG Wei, REN Jiansong, CHI Hui, DU ranran. Visualization Analysis of Literatures About Artificial Intelligence in Cancer Research[J]. Cancer Research on Prevention and Treatment, 2021, 48(2): 133-139. DOI: 10.3971/j.issn.1000-8578.2020.20.0657
    [5]WANG Xiangxu, PAN Wei, ZHANG Qiong, HUANG Luguang, ZHANG Hongmei. Advances in Artificial Intelligence-assisted Diagnosis of Malignant Tumors[J]. Cancer Research on Prevention and Treatment, 2020, 47(10): 788-792. DOI: 10.3971/j.issn.1000-8578.2020.20.0001
    [6]SHEN Xiaohan, DU Xiang. Application of Artificial Intelligence in Pathological Diagnosis[J]. Cancer Research on Prevention and Treatment, 2020, 47(7): 487-491. DOI: 10.3971/j.issn.1000-8578.2020.19.1131
    [7]DENG Kangli, CUI Diansheng, LUO Bo, JIA Quan'an, LIU Sanhe, HUANG Lei, ZHU Hui, WEI Shaozhong. Efficacy of Definitive External-beam Radiotherapy Versus Radical Prostatectomy on Clinically Localized High-risk Prostate Cancer Patients: A Retrospective Study[J]. Cancer Research on Prevention and Treatment, 2019, 46(12): 1113-1117. DOI: 10.3971/j.issn.1000-8578.2019.19.0965
    [8]LU Jingning, YANG Hong, PENG Minhao, XIAO Kaiyin, PENG Tao, PENG Jinbo. Percutaneous Ultrasound-guided Radiofrequency Ablation with Artificial Ascites for Hepatocellular Carcinoma in Hepatic Dome[J]. Cancer Research on Prevention and Treatment, 2015, 42(05): 493-497. DOI: 10.3971/j.issn.1000-8578.2015.05.016
    [9]Cai Hongning, Zhang Lei, Zhang Dunlan, Gao Han, Luo Jun. Application of Artificial Neural Networks in Prediction of Prognosis of Cervical Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(09): 1117-1119. DOI: 10.3971/j.issn.1000-8578.2012.09.015
    [10]ZHU Yu, WU Yu-xuan, ZHOU Wen-long, et al. 26 Cases of Advanced Prostatic Cancer Managed by Transurethral Prostatectomy Department of Urology[J]. Cancer Research on Prevention and Treatment, 2001, 28(05): 390-391. DOI: 10.3971/j.issn.1000-8578.973

Catalog

    Corresponding author: DENG Kangli, dengkangli10@163.com

    1. On this Site
    2. On Google Scholar
    3. On PubMed
    Article views (5044) PDF downloads (4539) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return